Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-04-15
1997-12-30
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544328, 544331, 544360, 544363, 544376, 544380, A61K 31495
Patent
active
057030839
ABSTRACT:
Disclosed are compounds of the formula: ##STR1## or the pharmaceutically acceptable acid addidon salts thereof wherein: R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, and R.sub.7 independently represent hydrogen, halogen, hydroxy, alkyl, alkoxy, amino, aminosulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl, cyano, nitro, trifluoromethyl, or trifluoromethoxy;
REFERENCES:
patent: 5250528 (1993-10-01), Oku et al.
patent: 5364849 (1994-11-01), Cliffe et al.
patent: 5395835 (1995-03-01), Glase et al.
Murray et al., (1995), "A Novel Series of Arylpiperazines with High Affinity and Selectivity for the Dopamine D.sub.3 Receptor," Bioorg. Med. Chem. Let., vol. 5, No. 3, pp. 219-222.
Chen Xi
Yuan Jun
Bucknum Michael
Neurogen Corporation
Shah Mukund J.
LandOfFree
N-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine recepto does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine recepto, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine recepto will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-202483